Philochem ^None

Philochem is a subsidiary of Philogen and is located in Zurich, Switzerland. It was established in 2006 and focuses on innovating ligand discovery and medicinal target identification. The company has developed various methodologies, including the construction and screening of DNA-encoded chemical libraries, small molecule-drug conjugates for cancer therapy, radiolabeled ligands for cancer imaging, chemical proteomics methodologies for pharmaceutical target discovery, and mass spectrometric characterization of MHC peptidomes for immunomodulatory strategies. These technologies are used in drug discovery and product development programs.